Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 235
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07040826 | Lifitegrast Eye Drops in Healthy Subjects：Phase I Study | ||
| NCT05278832 | A Study of QLS31905 in Patients With Advanced Solid Tumors | ||
| NCT06403735 | A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors | ||
| NCT04864782 | QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer | ||
| NCT06932094 | Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors | ||
| NCT05932888 | Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects | ||
| NCT03381430 | Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR | ||
| NCT07294300 | A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies | ||
| NCT07377773 | QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis | ||
| NCT07489586 | A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration | ||
| NCT06936748 | SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors | ||
| NCT06500507 | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT06633718 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI | ||
| NCT03267654 | Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance | ||
| NCT05703204 | A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | ||
| NCT06254235 | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | ||
| NCT04296994 | A Study of QL1706 in Subjects With Advanced Malignant Tumor | ||
| NCT05822713 | A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. | ||
| NCT06058000 | A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis | ||
| NCT07018050 | Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma | ||
| NCT05329025 | A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer | ||
| NCT07256782 | A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors | ||
| NCT04527068 | QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer | ||
| NCT05543343 | Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. | ||
| NCT07358884 | First in Human Study of QLS5316 in Solid Tumors | ||
| NCT06614907 | A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® | ||
| NCT07679711 | Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects | ||
| NCT07502014 | A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer | ||
| NCT07345000 | A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia | ||
| NCT07636707 | QLF4113 in Participants With Metastatic Prostate Cancer | ||
| NCT06383767 | A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer | ||
| NCT07462442 | Study of QLS5308 in Patients With Advanced Solid Tumors | ||
| NCT06940336 | To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy | ||
| NCT06949761 | A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation | ||
| NCT06732323 | A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer | ||
| NCT07667751 | An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer | ||
| NCT04234594 | Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. | ||
| NCT03104010 | A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD | ||
| NCT07716449 | QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ | ||
| NCT07455006 | Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients | ||
| NCT07416058 | PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC | ||
| NCT07463573 | QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma | ||
| NCT05262413 | A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) | ||
| NCT05150405 | A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors | ||
| NCT05758519 | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | ||
| NCT04157699 | An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b | ||
| NCT07450378 | QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT06644495 | Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib | ||
| NCT06898060 | To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture |
